1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Liver Cancer Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Liver Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Liver Cancer Diagnostics Market Regional Analysis
6.2 Europe Liver Cancer Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Liver Cancer Diagnostics Market Forecast Analysis
7. Europe Liver Cancer Diagnostics Market Analysis – by Type
7.1 Laboratory Tests
- 7.1.1 Overview
- 7.1.2 Laboratory Tests: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Endoscopy
- 7.2.1 Overview
- 7.2.2 Endoscopy: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Imaging
- 7.3.1 Overview
- 7.3.2 Imaging: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Biopsy
- 7.4.1 Overview
- 7.4.2 Biopsy: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Liver Cancer Diagnostics Market Analysis – by End User
8.1 Hospitals and Diagnostic Laboratories
- 8.1.1 Overview
- 8.1.2 Hospitals and Diagnostic Laboratories: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Academic and Research Institutes
- 8.2.1 Overview
- 8.2.2 Academic and Research Institutes: Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 CRO Laboratories
- 8.3.1 Overview
- 8.3.2 CRO Laboratories : Europe Liver Cancer Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Liver Cancer Diagnostics Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Liver Cancer Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Europe Liver Cancer Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.1.2 UK: Europe Liver Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.2.2 Germany: Europe Liver Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.3 France:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.3.2 France: Europe Liver Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.4.2 Russia: Europe Liver Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.5.2 Italy: Europe Liver Cancer Diagnostics Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Liver Cancer Diagnostics Market Breakdown, by Type
- 9.2.1.6.2 Rest of Europe: Europe Liver Cancer Diagnostics Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 bioMerieux SA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Illumina, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Koninklijke Philips N.V.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 QIAGEN
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Siemens Healthineers AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 THERMO FISHER SCIENTIFIC INC.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GE Healthcare
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Perspectum
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Liver Cancer Diagnostics Market
